Repository logo
 
Publication

Other indications for surfactant].

dc.contributor.authorPROENÇA FERNANDES, E.
dc.contributor.authorCARVALHO, C.
dc.contributor.authorSILVA, A.
dc.contributor.authorFERREIRA, P.
dc.contributor.authorALEGRIA, A.
dc.contributor.authorLOPES, L.
dc.contributor.authorAREIAS, M.A.
dc.date.accessioned2010-08-25T11:15:12Z
dc.date.available2010-08-25T11:15:12Z
dc.date.issued2002-01
dc.description.abstractAn Esp Pediatr. 2002 Jan;56(1):45-8. [Other indications for surfactant] [Article in Spanish] Proença Fernandes E, Carvalho C, Silva A, Ferreira P, Alegria A, Lopes L, Areias MA. Unidades de Cuidados Intensivos Neonatales y Pediátricos, Hospital Maria Pia, Spain. Abstract OBJECTIVE: The introduction of surfactant replacement therapy in the management of respiratory distress syndrome in the premature infant was a remarkable advance in neonatal intensive care. In the last few years, recognition of the role played by surfactant inactivation in the pathogenesis of other respiratory diseases of the newborn has justified new therapeutic applications. The aim of this study was to evaluate the efficacy of treatment with natural exogenous surfactant in situations with secondary surfactant deficiency. METHODS: We performed a retrospective analysis of the evolution of 15 newborn infants treated with natural exogenous surfactant. Nine infants had meconium aspiration syndrome, five had congenital pneumonia and one had adult respiratory distress syndrome. Oxygenation indexes before and after surfactant treatment as well as clinical and radiographic evolution were compared. RESULTS: The 12 surviving infants showed improvement in oxygenation and radiographic alterations after surfactant administration. Three patients with meconium aspiration syndrome died. CONCLUSIONS: These results support the therapeutic use of exogenous surfactant in severe respiratory diseases of the newborn causing secondary surfactant deficiency. PMID: 11792244 [PubMed - indexed for MEDLINEpor
dc.identifier.issn0302-4342
dc.identifier.urihttp://hdl.handle.net/10400.16/435
dc.language.isoengpor
dc.publisherAsociación Españoles de Pediatríapor
dc.titleOther indications for surfactant].por
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceMadridpor
oaire.citation.titleAnales Espanoles de Pediatriapor
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Doc.7.docx
Size:
12.79 KB
Format:
Microsoft Word XML
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: